Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 441 No. 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Classification Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Process improvement Section (Bio, Synthesis) Synthesis The Name of Products Gentacin Pediatric inj Main Ingredient Gentamicin sulfate Use (Indications) Formulation The Date of Sales injection 1998/12 Synthesis Gentacin inj injection 1998/12 Synthesis Wellcon tab Calcium polycargophil tablet 2005/07 Synthesis Mylax powder Polyethylene glycol Powder 2006/07 Synthesis Remid tablet Rebamipide tablet 2003/04 Synthesis Sulpid tablet Levosulpride tablet 2000/09 Synthesis Bioflor 250 powder Powder 1999/07 Saccharomyces Synthesis Bioflor 250 cap capsule 1994/04 boulardⅡ Synthesis Bioflor S cap capsule 1998/12 Synthesis Lodine tab 100mg tablet 1989/09 Synthesis Lodine tab 200mg tablet 1989/09 Etodolac Synthesis Lodine cap 200mg capsule 1987/06 micronized Synthesis Lodine tab 600mg tablet 1995/05 Synthesis Lodine XL tab 400mg tablet 1999/07 Synthesis Clidol tablet 100mg Sulindac tablet 1990/1 Synthesis Clidol tablet 200mg tablet 1989/12 Synthesis Boomiq tablet Bucillamine tablet 2001/09 Synthesis Thiosina tablet Thiocolchicoside / Amorphous aescin tablet 1995/09 Synthesis Mucoril cap Thiocolchicoside capsule 1987/08 Synthesis Pulmican sus Budesonide micronized Synthesis Aventro inhalation sol lpratropium Br. Synthesis Formaerol Dry Syrup Formoterol Fumarate suspension inhalation 2004/02 2006/05 syrup 2003/01 Synthesis Buropil cap AcebrophylⅡne capsule 2005/06 Synthesis Azestin tab Azelastine HCl tablet 2002/12 Expected Exporting Countries Etc.
442 2007 Korea Pharmaceutical Industry Directory No. Classification Section (Bio, Synthesis) The Name of Products Main Ingredient Use (Indications) Formulation The Date of Sales Expected Exporting Countries Etc. 46 Process improvement Synthesis Salcatonin inj Salcatonin injection 1991/02 47 Process improvement Synthesis Kuhnil Alrendron acid Na tab 70mg Alendronate sodium tablet 2006/04 48 49 Process improvement Process improvement Synthesis Kuhnil memantine HCl sol Memantine HCl Solution 2006/02 Synthesis Kuhnil memantine HCl tab tablet 2006/03 50 Process improvement Synthesis Prandin tab 6mg Deflazacort micronized tablet 1996/05 51 52 Process improvement Process improvement Synthesis Synthesis Kuhnil Gabapentin cap 100mg Kuhnil Gabapentin cap 300mg Gabapentin capsule 2006/03 capsule 2005/02 53 Process improvement Synthesis Kuhnil Clopidogrel tab Clopidogrel hydrogen sulfate tablet 2007/1 54 new drug Synthesis Omacor soft cap Omega-3-acid ethyl esters 90 capsule 2006/5 55 56 57 58 Process improvement Process improvement Process improvement Process improvement Synthesis Santoz Simvastatin Simbastatin tablet 2006/7 Synthesis Kuhnil Felodipine tab 5mg Felodipine tablet 2005/12 Synthesis Amilo tab Amiloride HCl tablet 1989/01 Synthesis Kuhnil Ramipril tab Ramipril tablet 2006/02 59 Process improvement Synthesis Kuhnil Glimepiride tab 2mg Glimepiride tablet 2004/07 60 Process improvement Synthesis Elcartin tab Acetyl-L-Carnitine HCl tablet 2002/09 3. R&D Figures No Classification Section (Bio, Synthesis) The Name of Technology Main Ingredient Use (Indications) The Duration of Development The Stage of Development Future Plan Expected Licencing (Domestic, Oversea) 1. IMD Formulation Nano-emulsion propofol formulation with the lowered side effects and improved product stabili Propofol Systemic Anesthetics 3years Launched Licensing Out Oversea
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
The Annex
Page 38 and 39:
316 2007 Korea Pharmaceutical Indus
Page 40 and 41:
The Korean Pharmaceutical Company L
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
4. Company Map The Korean Pharmace
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113: The Korean Pharmaceutical Company L
Page 200 and 201: 4. Company Map The Korean Pharmace
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

Create successful ePaper yourself

Delete template?

Save as template?